A Study to Evaluate the Efficacy and Safety of LZM012

NCT06110676 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

918

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: LZM012
BIOLOGICAL: Secukinumab

Sponsor

Livzon Pharmaceutical Group Inc.